CXCR2 and melanoma: In the case of melanoma, mouse xenograft models provide compelling evidence that tumor cells take advantage of CXCR2 ligand expression to either suppress the anti-tumor immune response or to induce tumor growth and angiogenesis, alter the TME, and facilitate metastasis [3, 14].